Synthesis and Antiproliferative Activity of New Thiosemicarboxamide Derivatives

Jun Wu,Yafei Guo,Jun Chen,Sangsang Hu,Ke Sun,Hongyu Hu,Meijuan Fang,Yuhua Xue
DOI: https://doi.org/10.1002/cbdv.202100671
2021-01-01
Chemistry & Biodiversity
Abstract:To discover new anticancer agents, two series of thiosemicarboxamide derivatives were synthesized and evaluated for their antiproliferative activity against human cancer cells in vitro. Most target compounds (especially 3f, 3g, and 3h) exhibit potent antiproliferative activity against HeLa cells. Importantly, compound 3h, bearing a 4-methylphenyl substituent at N position of thiourea moiety, has significant and broad-spectrum inhibitory activities against cancer cells (HepG2, HeLa, MDA-MB231, A875, and H460 cells) with low IC50 values (<5.0 mu M) and shows low toxicity to normal LO2 and MRC-5 cells. Further studies show that compound 3h exerts high inhibitory activity in cancer cells by inducing the G2/M-phase arrest of cancer cells. Collectively, this study presents compound 3h as a new entity for the development of cell cycle arrest inducers for the treatment of cancer.
What problem does this paper attempt to address?